10 years and $1 billion. That's how long and how expensive the average clinical trial in the U.S. is. Even then, only 1 in 10 prospective treatments is ultimately approved for use by the Food and Drug Administration (FDA). Under normal circumstances, these conditions are daunting; during an emergency, they are lethal. Stakeholders have long pushed for improvements to be made to the clinical trial process, hoping for faster results, cheaper cures and broader participation by both patients